Labcorp has announced significant improvements to its Global Trial Connect™ platform, aimed at helping sponsors and investigator sites manage the complexities of clinical trials. This platform serves as a vital resource, offering a comprehensive suite of clinical trial services, data, and technology to enhance delivery and efficiency.
Streamlined Digital Experience
The updated Global Trial Connect™ features redesigned portals for both Labcorp Sponsor™ and Labcorp Investigator™ experiences. These enhancements are designed to provide clearer visibility into studies, simplify workflows, and facilitate quicker, more informed decision-making. Brian Caveney, M.D., Labcorp’s Executive Vice President, emphasizes that as clinical trials grow more intricate, the need for effective technology becomes paramount. The new features allow clients to focus on advancing research and supporting patients, rather than getting bogged down by operational tasks.
Customer-Centric Improvements
The enhancements to Global Trial Connect™ were developed with direct input from over 80 sponsors and 100 investigator sites worldwide. Labcorp actively sought extensive customer feedback and conducted product testing to ensure these updates directly address user needs. Such a collaborative approach not only refines the platform but also aligns its functionality with the current demands of the clinical trial landscape.
Future-Forward Clinical Trials
This latest iteration of Global Trial Connect™ exemplifies Labcorp’s commitment to investing in digital solutions within its Biopharma Laboratory Services division. These improvements enable sponsors and investigator sites to conduct high-quality clinical trials more effectively. Labcorp is dedicated to evolving Global Trial Connect™ further, continually adapting to emerging industry challenges and fostering a more interconnected experience throughout the clinical trial lifecycle.
Key Features of the Updated Platform
The redesigned platform includes several notable updates aimed at enhancing user experience:
- Improved data visibility across studies
- Simplified workflows for better operational efficiency
- Enhanced tools for managing study activities
These features help streamline processes, allowing clinical trial stakeholders to focus on what truly matters: the advancement of research and patient care.
Commitment to Quality and Innovation
Labcorp’s nearly 71,000 employees are dedicated to delivering innovative laboratory services that empower healthcare providers, pharmaceutical companies, and researchers. The company has played a crucial role in supporting the approval of over 85% of new drugs and therapeutic products by the FDA in recent years, reflecting its status as a leader in the industry.
Conclusion
Labcorp’s enhancements to Global Trial Connect™ represent a significant step forward in the realm of clinical trials. By prioritizing user feedback and investing in advanced digital solutions, Labcorp is not only simplifying the complex nature of clinical trials but also positioning itself as a pivotal player in the future of healthcare research. These developments promise to enhance the efficiency and quality of clinical trial delivery, ultimately benefiting patients and innovators alike.
- Takeaway Points:
- Global Trial Connect™ improvements enhance visibility and streamline workflows.
- Labcorp’s updates are guided by extensive customer feedback.
- The platform aims to simplify clinical trial complexities and support research advancements.
Read more → www.tmcnet.com